Industry Verticals »

All Categories

Insights »

About TMR »

Next Generation Sequencers (NGS) Market

Next Generation Sequencers (NGS) Market (By Product: Instruments, Consumables, Services; By Technology: Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing, Other Sequencing Technologies; By Workflow: Pre-Sequencing, Sequencing, Data Analysis; By Application: Clinical Diagnostics, Oncology, Reproductive Health, Infectious Disease Detection, Agrigenomics & Forensics, Drug Discovery & Development, Others; and by End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2036

Next Generation Sequencers (NGS) Market Outlook 2036

The global next generation sequencers (NGS) market size was valued at USD 10.8 Billion in 2025 and is projected to reach USD 47.2 Billion by 2036, expanding at a CAGR of 14.4% from 2026 to 2036. The market is projected to witness growth due to rising use of genomic testing, precision medicine, and clinical diagnostics. Advances in sequencing platforms, automation, and bioinformatics are enhancing the accessibility of NGS technology in healthcare and research environments. Additionally, increased funding for genomics research and broader applications in oncology, rare diseases, and infectious disease testing are contributing to market development

Market Size & Highlights

  • The next generation sequencers (NGS) market reached USD 10.8 Billion in 2025.
  • The market is estimated to reach USD 47.2 Billion by 2036
  • The next generation sequencers (NGS) industry is anticipated to expand at a CAGR of 14.4% from 2026 to 2036.
  • Top companies include Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Agilent Technologies, Inc., etc.
  • North America dominated the market in 2025, holding the largest revenue share of 44.3%.
  • By product, the consumables segment held the major market share of 49.8% in 2025.

Next Generation Sequencers (ngs) Market By Revenue

Analysts’ Viewpoint on the Next Generation Sequencers (NGS) Market

The next generation sequencers (NGS) market is poised for steady growth as genomic technologies continue to find their way into routine healthcare and life science research applications. Adoption is increasing across hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology companies, and research institutions as sequencing platforms are increasingly used for disease diagnosis, biomarker discovery, and personalized treatment planning.

The increasingly widespread application of NGS within oncology, rare disease diagnosis, reproductive health and infectious disease surveillance is expected to continue to significantly contribute to long-term demand. Continued technological innovation is intensifying competition among market participants. The companies are thus working on sequencing speed, accuracy, throughput and automation and at the same time on user-friendly bioinformatics software for analysis of genomic data. These developments are bringing sequencing within the reach of more clinicians and researchers. Falling sequencing costs and increasing government funding for genomics programs are driving adoption in both developed and emerging markets.

Despite the positive expectations, high capital investment needed and complexity of data analysis and regulatory compliance are still significant challenges, especially for small laboratories and healthcare providers. Data retention, cybersecurity and the lack of qualified bioinformatics personnel continue to have an impact on purchasing decisions. However, as a result of continuing development of artificial intelligence, cloud-based genomic analysis, and portable sequencing technologies, it is anticipated that these workflow obstacles will be mitigated to an even greater extent. The market is expected to retain a high degree of innovativeness, with product launches, strategic collaborations, and clinical applications expanding continuously and driving growth in the future.

Next Generation Sequencers (NGS) Market Introduction

Next Generation Sequencers (NGS) Market is poised to register strong growth throughout the forecast period, mainly because of the rising use of precision medicine, oncological diagnosis, detecting rare diseases, and population level genomics. The adoption of next generation sequencing devices by health care organizations and research institutes for creating detailed genetic data at higher speeds and with increased accuracy, cost-effectiveness and precision than other conventional approaches is one of the key factors driving the market growth. Increasing incidence of cancers and genetic diseases is boosting the demand for genomics and biomarkers, which has made NGS a critical part of the diagnosis process.

The innovations in terms of sequencing technology, automation, sample handling, and bioinformatics are enhancing the capabilities of sequencing throughput and data analysis. The declining cost and improved availability of genetic tests are motivating stakeholders to use sequencing more frequently. The increase in government funding for genomics research and precision medicine programs is also improving the market outlook. With the increasing importance of personalized medicine, the NGS market is anticipated to exhibit robust future growth.

Attribute Detail
Market Drivers
  • Growing Adoption of Precision Medicine and Personalized Healthcare
  • Continuous Advancements in HT Sequencing Technologies

Growing Adoption of Precision Medicine and Personalized Healthcare Accelerating Demand for Next Generation Sequencers

Increasing implementation of precision medicine and personalized treatment plans has emerged as one of the major factors propelling the next generation sequencers (NGS) market. Healthcare is moving from generalized standard treatment procedures towards personalized treatment procedures that are influenced by the patient’s genetic profile, thus requiring genomic sequencing to become an instrumental component of clinical decision making. NGS technology facilitates this shift through the rapid detection of disease-causing mutations, discovery of biomarkers, pharmacogenomics analysis and patient stratification for treatment options. In 2024, the NIH All of Us Research Program identified more than 275 million previously unknown genetic variations based on genomic data from close to 250,000 whole-genome sequences, including more than 4 million variants located in regions potentially associated with disease risk. This huge amount of genomic information has been used to enhance knowledge of the biology of disease and develop personalized treatments.

As per the National Institute of Health (NIH), the All of Us Research Program has an objective of recruiting one million or more individuals in order to make available to researchers one of the largest databases in the world that can be used for the research related to precision medicine. In the year 2025, the program expanded its genetic, electronic health records, lifestyle, and environmental data. There are also ongoing efforts to make precision medicine more common in the field of oncology, rare disease diagnosis, genetic disorder testing and pharmacogenomics, where genome sequencing is important for choosing the right treatment method. The growing number of genomics projects funded by national governments or research organizations, as well as population-scale genomic databases. With the penetration of precision medicine in regular clinical practice, the need for high-throughput sequencing technologies will keep increasing, thus offering long-term growth opportunities to the NGS market players at a global level.

Continuous Advancements in High-Throughput (HT) Sequencing Technologies Driving Widespread Adoption of Next Generation Sequencers

The next generation sequencers (NGS) market is growing substantially on account of continuous developments in high throughput sequencing technologies that enhance the sequencing speed, accuracy, scalability, and quality of data. Modern sequencing platforms can process large numbers of DNA and RNA samples in parallel, enabling healthcare providers and researchers to produce genomic information with unprecedented efficiency. According to the NHGRI of the NIH, the continuing research is geared towards coming up with new genomic technologies that will take research and clinical genomics to levels beyond the current one, paying particular attention to sequencing quality, minimizing analytical challenges, and making wider clinical application possible.

As mentioned by the United States Department of Energy Joint Genome Institute (JGI), the total sequencing output of long-read sequencing was around 578.8 terabases (Tb) in FY 2025, whereas short-read sequencing had an approximate output of 565.4 Tb. Therefore, the total output of sequencing was more than 1,144 Tb per year. It shows that there is a fast growth in sequencing power available for research. As noted by the NIH, the NHGRI supports several programs for advancing human genomics research and the implementation of sequencing technologies in clinical practice. Advances in sequencing chemistry, automation, library preparation, and bioinformatics are helping labs conduct larger-scale analyses with more accuracy while shortening time to results. Such advancements will help in expanding the usage of NGS for oncology, diagnosis of rare diseases, infectious disease surveillance, reproductive health, and population genomics. Higher sequencing capacity also allows research institutions to carry out massive genomic studies which would otherwise be impossible to perform due to technical limitations and costs. With continued improvement in high-throughput sequencing techniques, the capability of obtaining genomic data more quickly and effectively will remain an important factor supporting market growth in the global next generation sequencers (NGS) market.

Attribute Detail
Market Opportunities
  • Expansion of NGS-Based Clinical Diagnostics in Emerging Markets

Expansion of NGS-Based Clinical Diagnostics in Emerging Markets Creating Significant Growth Opportunities

Growing availability of next generation sequencing (NGS)-based clinical diagnostics in emerging markets is expected to offer significant growth opportunities for the global NGS market. Several developing countries are bolstering genomic medicine capabilities via government-funded healthcare programs and investments in molecular diagnostic laboratories as well as through national genomics initiatives. These initiatives are expanding the availability of state-of-the-art genetic testing for cancer, rare diseases, inherited disorders and infectious disease. As per reports provided by the World Health Organization (WHO) in 2023, it was demonstrated that there was ongoing cooperation between countries and regional laboratories in the area of sequencing capability.

The growth in the genomic surveillance infrastructure has led to an increase in sequencing technologies that can be used for the diagnosis of diseases other than infectious diseases. As per WHO, the human genomics initiative that was started in 2024 is aimed at assisting in the equitable use of genomic technologies and increasing access to genomic medicine in underserved areas through robust health systems, governance, and workforce development. Clinical testing using genomic testing is now increasingly used by emerging economies in Asia, Latin America, the Middle East, and Africa in their national healthcare plans to enhance the accuracy of disease diagnosis and treatment planning. With increased government investment, development of healthcare infrastructure and increasing awareness about the concept of precision medicine, a conducive environment is being created for adoption of clinical testing using next-generation sequencing by hospitals and laboratories. With increasing availability of genomic tools in such regions, companies manufacturing sequencing instruments, consumables and bioinformatics solutions are expected to benefit from significant growth opportunities in clinical diagnostics.

Consumables Holds the Largest Share in the Product Segment

Next Generation Sequencers (ngs) Market By Type

Among the product segments, Consumables hold the dominant position and account for approximately 49.8% share of the total market as every sequencing workflow requires an uninterrupted provision of the library preparation kits, sequencing reagents, flow cells, sample preparation products, and quality control materials. In contrast to the one-off purchase of sequencing equipment, consumables are needed for each sequencing run, and thus there is a recurring demand at the level of research labs, hospitals, and clinical diagnostic centers. Growing number of genomic tests being conducted in oncology, rare diseases, infectious diseases and reproductive health is further boosting the sequencing consumables demand.

According to the National Institutes of Health (NIH), All of Us Research Program by 2025 had recruited more than 890,000 people, and out of them, about 650,000 people had contributed their bio-specimen to perform genome study. All of Us have become one of the largest biological sample repositories in the world, which requires constant use of sequencing reagents, sample preparation kits, and other lab consumables. As per the National Cancer Institute (NCI), The Cancer Genome Atlas (TCGA) still represents one of the biggest open sources for cancer genomics, which contains molecular and genomic information from over 20,000 samples of primary tumor and matched normal samples representing 33 types of cancer, and is continuing to serve researchers in the field of genomics.

As per the Centers for Disease Control and Prevention (CDC), the Pathogen Genomics Program will further continue to enhance the work done in genomic surveillance in 2024-2025 by providing routine sequencing of pathogens via public health laboratory networks in the United States. With an increasing number of sequencing studies being conducted, coupled with increased clinical applications of genomics and expansion of precision medicine programs, it will result in repeated purchases of consumables, thus becoming the largest revenue generator in the next generation sequencers (NGS) market globally.

Regional Outlook of Next Generation Sequencers (NGS) Market

Next Generation Sequencers (ngs) Market By Region

Attribute Detail
Leading Region
  • North America

North America leads the next generation sequencers (NGS) market which is expected to reach 44.3% of the global market share in 2025, owing to the fact that there are high investments in genomics research, advanced healthcare infrastructure, increasing penetration of precision medicine and consistent government support for large-scale sequencing programs. The region is also supported by leading sequencing technology developers, established clinical laboratories, and a research environment that fosters molecular diagnostic innovation. The NIH says that the agency spent roughly USD 48 billion on medical research in FY 2025, with a substantial amount being used for the funding of programs such as genomics, precision medicine, rare disease research, and cancer genomics.

As reported by the National Institutes of Health (NIH), the All of Us Research Program reached a significant milestone by increasing its number of participants to more than 883,000. With the release of its biggest data set, the research program has provided health data for more than 747,000 participants, of whom 535,000 have whole genome sequence data associated with their electronic health records. The high level of national genomic projects, increasing adoption of sequencing-based analysis in clinical diagnostics, and consistent support for life science research ensure that North America will continue to remain dominant in the global NGS market.

Analysis of Key Players in Next Generation Sequencers (NGS) Market

The NGS market is competitive and companies compete on sequencing accuracy, throughput, automation, workflow integration, and bioinformatics capabilities. Illumina, Inc. retains a robust position due to its high-throughput sequencing platforms in addition to a wide range of sequencing consumables which have application in the research and clinical diagnostic laboratories. Thermo Fisher Scientific, Inc. has also established a strong presence with its comprehensive sequencing workflows for instruments, reagents, software, and molecular diagnostic solutions.

Pacific Biosciences of California, Inc. holds a competitive edge through the utilization of long read sequencing which enables detection of structural variants as well as the analysis of complex genomes. Oxford Nanopore Technologies plc is known for the provision of portable, real time sequencing solutions which allow quick genomic analysis. F. Hoffmann-La Roche Ltd. has been further developing its genomics capabilities through the integration of sequencing technologies into diagnostics and precision medicine applications. With rising public investment in genomics, growing demand for clinical sequencing and innovation in products, firms have been motivated to make strategic partnerships, increase sequencing capabilities and create sophisticated software to analyze data.

Key Developments in Next Generation Sequencers (NGS) Market

  • In February 2025, F. Hoffmann-La Roche Ltd, a multinational pharmaceutical firm engaged in healthcare and diagnostics, has released its own technology called Sequencing by Expansion (SBX) technology and the AXELIOS platform for DNA sequencing. This release has brought about a novel method of next-generation sequencing capable of providing fast and highly accurate results in sequencing.
  • In February 2025, Illumina, Inc. announced a new portfolio of multiomics technologies at the Advances in Genome Biology and Technology (AGBT) Annual Meeting. The company presented innovative genomics, spatial biology, single-cell, CRISPR, and methylation products that use next-generation sequencing technologies.
  • In January 2025, Illumina, Inc., a leading developer of DNA sequencing technologies, announced transformative innovations to the NovaSeq X Series with the introduction of the NovaSeq X Single Flow Cell System, software updates, and new sequencing kits. The upgrades were designed to enhance sequencing performance, enable multiomic applications, and bring high-throughput sequencing to more labs, regardless of sample volume.

Next Generation Sequencers (NGS) Market Snapshot

Attribute Detail
Size in 2025 USD 10.8 Billion
Forecast Value in 2036 USD 47.2 Billion
CAGR 14.4%
Forecast Period 2026-2036
Historical Data Available for 2021-2025
Quantitative Units USD Billion
Next Generation Sequencers (NGS) Market Analysis It includes segment analysis and regional level analysis. Qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation Product
  • Instruments
  • Consumables
  • Services
Technology
  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Nanopore Sequencing
  • Other Sequencing Technologies
Workflow
  • Pre-Sequencing
  • Sequencing
  • Data Analysis
Application
  • Clinical Diagnostics
  • Oncology
  • Reproductive Health
  • Infectious Disease Detection
  • Agrigenomics & Forensics
  • Drug Discovery & Development
  • Other Research Applications
End-user
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Clinical Laboratories
  • Contract Research Organizations (CROs)
  • Other End Users
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies plc
  • BGI Genomics Co., Ltd.
  • MGI Tech Co., Ltd.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Promega Corporation
  • New England Biolabs, Inc.
  • Eurofins Scientific SE
  • Macrogen, Inc.
  • Azenta, Inc.
  • Hamilton Company
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global next generation sequencers (NGS) market in 2025?

The market was valued at USD 10.8 Billion in 2025.

How big will the global next generation sequencers (NGS) industry be in 2036?

The industry is projected to reach USD 47.2 Billion by 2036.

What are the factors driving the next generation sequencers (NGS) market?

Growing adoption of precision medicine and personalized healthcare and continuous advancements in high-throughput sequencing technologies.

What will be the CAGR of the global next generation sequencers (NGS) market during the forecast period?

The market is anticipated to expand at a CAGR of 14.4% from 2026 to 2036.

Which region will account for the largest share of the next-generation sequencers (NGS) market during the forecast period?

North America is expected to maintain the largest global market share from 2026 to 2036.

Who are the prominent players in the global next generation sequencers (NGS) market?

Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Agilent Technologies, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, BGI Genomics Co., Ltd., MGI Tech Co., Ltd., Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Standard BioTools Inc., Takara Bio Inc., Promega Corporation, New England Biolabs, Inc., Eurofins Scientific SE, Macrogen, Inc., Azenta, Inc., and Hamilton Company among others.

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Next Generation Sequencers (NGS) Market
  4. Market Overview
    • Introduction
      • Segment Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Next Generation Sequencers (NGS) Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (US$ Bn)
  5. Key Insights
    • PESTLE Analysis
    • Porter's Five Forces Analysis
    • Value Chain Analysis
    • Supply Chain Analysis
    • Pricing Analysis
    • Technology Landscape Analysis
    • Regulatory Landscape Analysis
    • Investment & Funding Analysis
    • Merger & Acquisition Analysis
    • Partnership, Collaboration & Licensing Analysis
    • Go-to-Market (GTM) Strategy Analysis
    • Future Market Opportunities
    • Strategic Recommendations
  6. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Product
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Attractiveness Analysis, by Product
  7. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Surgery Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Attractiveness Analysis, by Surgery Type
  8. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Workflow
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Attractiveness Analysis, by Workflow
  9. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Application
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Attractiveness Analysis, by Application
  10. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by End-user
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis, by End-user
  11. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region, 2021-2036
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness Analysis, by Region
  12. North America Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  13. U.S. Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  14. Canada Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  15. Europe Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • The Netherlands
      • Switzerland
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  16. Germany Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  17. United Kingdom Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  18. France Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  19. Italy Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  20. Spain Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  21. The Netherlands Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  22. Switzerland Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  23. Rest of Europe Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  24. Asia Pacific Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • India
      • Japan
      • South Korea
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  25. China Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  26. India Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  27. Japan Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  28. South Korea Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  29. Australia & New Zealand Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  30. Rest of Asia Pacific Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  31. Latin America Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  32. Brazil Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  33. Mexico Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  34. Argentina Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  35. Rest of Latin America Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  36. Middle East & Africa Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
      • By Country/Sub-region
  37. GCC Countries Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  38. South Africa Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  39. Rest of Middle East & Africa Next Generation Sequencers (NGS) Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Instruments
      • Consumables
      • Services
    • Market Value Forecast, by Surgery Type, 2021-2036
      • Sequencing by Synthesis (SBS)
      • Ion Semiconductor Sequencing
      • Single-Molecule Real-Time (SMRT) Sequencing
      • Nanopore Sequencing
      • Other Sequencing Technologies
    • Market Value Forecast, by Workflow, 2021-2036
      • Pre-Sequencing
      • Sequencing
      • Data Analysis
    • Market Value Forecast, by Application, 2021-2036
      • Clinical Diagnostics
      • Oncology
      • Reproductive Health
      • Infectious Disease Detection
      • Agrigenomics & Forensics
      • Drug Discovery & Development
      • Other Research Applications
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals & Clinics
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Clinical Laboratories
      • Contract Research Organizations (CROs)
      • Other End Users
    • Market Attractiveness Analysis
      • By Product
      • By Surgery Type
      • By Workflow
      • By Application
      • By End-user
  40. Competition Landscape
    • Market Player - Competition Matrix (By Tier and Size of Companies)
    • Market Share Analysis, by Company, 2025
    • Company Profiles
      • Illumina, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • QIAGEN N.V.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Agilent Technologies, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Pacific Biosciences of California, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Oxford Nanopore Technologies plc
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • BGI Genomics Co., Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • MGI Tech Co., Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Danaher Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • PerkinElmer, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Standard BioTools Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Takara Bio Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Promega Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • New England Biolabs, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Eurofins Scientific SE
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Macrogen, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Azenta, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Hamilton Company
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments

List of Tables

Table 01: Global Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 02: Global Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 03: Global Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 04: Global Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 05: Global Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 06: Global Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 07: North America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 08: North America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 09: North America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 10: North America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 11: North America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 12: North America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 13: U.S. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 14: U.S. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 15: U.S. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 16: U.S. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 17: U.S. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 18: Canada Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 19: Canada Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 20: Canada Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 21: Canada Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 22: Canada Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 23: Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 24: Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 25: Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 26: Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 27: Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 28: Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 29: Germany Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 30: Germany Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 31: Germany Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 32: Germany Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 33: Germany Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 34: U.K. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 35: U.K. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 36: U.K. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 37: U.K. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 38: U.K. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 39: France Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 40: France Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 41: France Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 42: France Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 43: France Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 44: Italy Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 45: Italy Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 46: Italy Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 47: Italy Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 48: Italy Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 49: Spain Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 50: Spain Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 51: Spain Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 52: Spain Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 53: Spain Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 54: The Netherlands Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 55: The Netherlands Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 56: The Netherlands Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 57: The Netherlands Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 58: The Netherlands Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 59: Switzerland Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 60: Switzerland Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 61: Switzerland Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 62: Switzerland Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 63: Switzerland Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 64: Rest of Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 65: Rest of Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 66: Rest of Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 67: Rest of Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 68: Rest of Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 69: Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 70: Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 71: Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 72: Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 73: Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 74: Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 75: China Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 76: China Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 77: China Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 78: China Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 79: China Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 80: Japan Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 81: Japan Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 82: Japan Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 83: Japan Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 84: Japan Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 85: India Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 86: India Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 87: India Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 88: India Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 89: India Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 90: South Korea Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 91: South Korea Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 92: South Korea Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 93: South Korea Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 94: South Korea Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 95: Australia and New Zealand Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 96: Australia and New Zealand Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 97: Australia and New Zealand Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 98: Australia and New Zealand Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 99: Australia and New Zealand Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 100: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 101: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 102: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 103: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 104: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 105: Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 106: Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 107: Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 108: Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 109: Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 110: Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 111: Brazil Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 112: Brazil Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 113: Brazil Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 114: Brazil Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 115: Brazil Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 116: Mexico Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 117: Mexico Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 118: Mexico Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 119: Mexico Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 120: Mexico Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 121: Argentina Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 122: Argentina Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 123: Argentina Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 124: Argentina Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 125: Argentina Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 126: Rest of Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 127: Rest of Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 128: Rest of Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 129: Rest of Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 130: Rest of Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 131: Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 132: Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 133: Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 134: Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 135: Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 136: Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 137: GCC Countries Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 138: GCC Countries Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 139: GCC Countries Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 140: GCC Countries Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 141: GCC Countries Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 142: South Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 143: South Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 144: South Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 145: South Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 146: South Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 147: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Product, 2021 to 2036
Table 148: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 149: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Workflow, 2021 to 2036
Table 150: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by Application, 2021 to 2036
Table 151: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, by End-user, 2021 to 2036

List of Figures

Figure 01: Global Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 02: Global Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 03: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 04: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Instruments, 2021 to 2036
Figure 05: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Consumables, 2021 to 2036
Figure 06: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Services, 2021 to 2036
Figure 07: Global Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 08: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 09: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Sequencing by Synthesis (SBS), 2021 to 2036
Figure 10: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Ion Semiconductor Sequencing, 2021 to 2036
Figure 11: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Single-Molecule Real-Time (SMRT) Sequencing, 2021 to 2036
Figure 12: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Nanopore Sequencing, 2021 to 2036
Figure 13: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Other Sequencing Technologies, 2021 to 2036
Figure 14: Global Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 15: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 16: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Pre-Sequencing, 2021 to 2036
Figure 17: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Sequencing, 2021 to 2036
Figure 18: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Data Analysis, 2021 to 2036
Figure 19: Global Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 20: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 21: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Clinical Diagnostics, 2021 to 2036
Figure 22: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Oncology, 2021 to 2036
Figure 23: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Reproductive Health, 2021 to 2036
Figure 24: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Infectious Disease Detection, 2021 to 2036
Figure 25: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Agrigenomics & Forensics, 2021 to 2036
Figure 26: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Drug Discovery & Development, 2021 to 2036
Figure 27: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Other Research Applications, 2021 to 2036
Figure 28: Global Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 29: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 30: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Hospitals & Clinics, 2021 to 2036
Figure 31: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Academic & Research Institutes, 2021 to 2036
Figure 32: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Pharmaceutical & Biotechnology Companies, 2021 to 2036
Figure 33: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Clinical Laboratories, 2021 to 2036
Figure 34: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Contract Research Organizations (CROs), 2021 to 2036
Figure 35: Global Next Generation Sequencers (NGS) Market Revenue (USD Billion), by Other End Users, 2021 to 2036
Figure 36: Global Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 37: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 38: North America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 39: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 40: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 41: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 42: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 43: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 44: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 45: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 46: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 47: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 48: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 49: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 50: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 51: U.S. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 52: U.S. Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 53: U.S. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 54: U.S. Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 55: U.S. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 56: U.S. Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 57: U.S. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 58: U.S. Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 59: U.S. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 60: U.S. Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 61: U.S. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 62: Canada Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 63: Canada Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 64: Canada Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 65: Canada Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 66: Canada Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 67: Canada Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 68: Canada Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 69: Canada Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 70: Canada Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 71: Canada Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 72: Canada Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 73: Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 74: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 75: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 76: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 77: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 78: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 79: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 80: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 81: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 82: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 83: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 84: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 85: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 86: Germany Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 87: Germany Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 88: Germany Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 89: Germany Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 90: Germany Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 91: Germany Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 92: Germany Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 93: Germany Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 94: Germany Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 95: Germany Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 96: Germany Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 97: U.K. Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 98: U.K. Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 99: U.K. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 100: U.K. Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 101: U.K. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 102: U.K. Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 103: U.K. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 104: U.K. Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 105: U.K. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 106: U.K. Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 107: U.K. Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 108: France Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 109: France Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 110: France Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 111: France Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 112: France Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 113: France Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 114: France Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 115: France Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 116: France Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 117: France Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 118: France Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 119: Italy Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 120: Italy Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 121: Italy Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 122: Italy Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 123: Italy Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 124: Italy Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 125: Italy Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 126: Italy Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 127: Italy Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 128: Italy Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 129: Italy Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 130: Spain Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 131: Spain Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 132: Spain Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 133: Spain Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 134: Spain Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 135: Spain Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 136: Spain Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 137: Spain Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 138: Spain Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 139: Spain Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 140: Spain Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 141: The Netherlands Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 142: The Netherlands Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 143: The Netherlands Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 144: The Netherlands Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 145: The Netherlands Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 146: The Netherlands Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 147: The Netherlands Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 148: The Netherlands Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 149: The Netherlands Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 150: The Netherlands Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 151: The Netherlands Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 152: Switzerland Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 153: Switzerland Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 154: Switzerland Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 155: Switzerland Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 156: Switzerland Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 157: Switzerland Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 158: Switzerland Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 159: Switzerland Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 160: Switzerland Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 161: Switzerland Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 162: Switzerland Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 163: Rest of Europe Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 164: Rest of Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 165: Rest of Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 166: Rest of Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 167: Rest of Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 168: Rest of Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 169: Rest of Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 170: Rest of Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 171: Rest of Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 172: Rest of Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 173: Rest of Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 174: Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 175: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 176: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 177: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 178: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 179: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 180: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 181: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 182: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 183: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 184: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 185: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 186: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 187: China Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 188: China Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 189: China Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 190: China Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 191: China Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 192: China Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 193: China Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 194: China Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 195: China Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 196: China Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 197: China Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 198: Japan Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 199: Japan Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 200: Japan Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 201: Japan Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 202: Japan Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 203: Japan Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 204: Japan Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 205: Japan Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 206: Japan Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 207: Japan Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 208: Japan Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 209: India Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 210: India Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 211: India Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 212: India Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 213: India Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 214: India Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 215: India Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 216: India Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 217: India Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 218: India Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 219: India Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 220: South Korea Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 221: South Korea Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 222: South Korea Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 223: South Korea Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 224: South Korea Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 225: South Korea Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 226: South Korea Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 227: South Korea Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 228: South Korea Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 229: South Korea Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 230: South Korea Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 231: Australia and New Zealand Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 232: Australia and New Zealand Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 233: Australia and New Zealand Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 234: Australia and New Zealand Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 235: Australia and New Zealand Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 236: Australia and New Zealand Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 237: Australia and New Zealand Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 238: Australia and New Zealand Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 239: Australia and New Zealand Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 240: Australia and New Zealand Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 241: Australia and New Zealand Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 242: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 243: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 244: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 245: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 246: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 247: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 248: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 249: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 250: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 251: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 252: Rest of Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 253: Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 254: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 255: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 256: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 257: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 258: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 259: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 260: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 261: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 262: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 263: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 264: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 265: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 266: Brazil Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 267: Brazil Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 268: Brazil Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 269: Brazil Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 270: Brazil Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 271: Brazil Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 272: Brazil Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 273: Brazil Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 274: Brazil Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 275: Brazil Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 276: Brazil Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 277: Mexico Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 278: Mexico Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 279: Mexico Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 280: Mexico Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 281: Mexico Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 282: Mexico Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 283: Mexico Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 284: Mexico Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 285: Mexico Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 286: Mexico Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 287: Mexico Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 288: Argentina Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 289: Argentina Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 290: Argentina Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 291: Argentina Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 292: Argentina Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 293: Argentina Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 294: Argentina Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 295: Argentina Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 296: Argentina Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 297: Argentina Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 298: Argentina Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 299: Rest of Latin America Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 300: Rest of Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 301: Rest of Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 302: Rest of Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 303: Rest of Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 304: Rest of Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 305: Rest of Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 306: Rest of Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 307: Rest of Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 308: Rest of Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 309: Rest of Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 310: Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 311: Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 312: Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 313: Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 314: Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 315: Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 316: Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 317: Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 318: Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 319: Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 320: Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 321: Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 322: Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 323: GCC Countries Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 324: GCC Countries Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 325: GCC Countries Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 326: GCC Countries Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 327: GCC Countries Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 328: GCC Countries Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 329: GCC Countries Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 330: GCC Countries Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 331: GCC Countries Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 332: GCC Countries Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 333: GCC Countries Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 334: South Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 335: South Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 336: South Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 337: South Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 338: South Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 339: South Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 340: South Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 341: South Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 342: South Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 343: South Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 344: South Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 345: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value (USD Billion) Forecast, 2021 to 2036
Figure 346: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Product, 2025 and 2036
Figure 347: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 348: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Technology, 2025 and 2036
Figure 349: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 350: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Workflow, 2025 and 2036
Figure 351: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Workflow, 2026 to 2036
Figure 352: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Application, 2025 and 2036
Figure 353: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 354: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by End-user, 2025 and 2036
Figure 355: Rest of Middle East and Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved

Next Generation Sequencers (NGS) Market

Buy This ReportBuy Now